The daily business briefing: August 19, 2022

The Biden administration moves toward shifting COVID shot costs to insurers, Bed Bath & Beyond shares dive after activist investor sells stake, and more

A Bed Bath and Beyond store
(Image credit: Justin Sullivan/Getty Images)

1. Biden administration prepares to shift COVID treatment costs to insurers

The Biden administration is preparing to stop paying for COVID-19 shots and treatments as cases drop and pandemic funding runs low, The Wall Street Journal reported Thursday. The Biden and Trump administrations always planned to shift control and responsibility for coverage to the health-care industry, said Dawn O'Connell, assistant U.S. health secretary for preparedness and response. "We've known at some point we'd need to move over into the commercial market, and we're approaching that time now." The transition could take months. The Department of Health and Human Services has scheduled an Aug. 30 planning session that will include drugmakers, pharmacies, and state public health officials.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.